GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 915 filers reported holding GLAXOSMITHKLINE PLC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $766,202,000 | +4.0% | 17,601,698 | +4.1% | 0.08% | +28.8% |
| Q1 2022 | $736,836,000 | -5.9% | 16,915,438 | -4.7% | 0.06% | +1.7% |
| Q4 2021 | $782,670,000 | +18.6% | 17,747,631 | +2.8% | 0.06% | +11.5% |
| Q3 2021 | $659,884,000 | -2.4% | 17,269,912 | +1.7% | 0.05% | -1.9% |
| Q2 2021 | $676,033,000 | +10.5% | 16,977,229 | -1.0% | 0.05% | +1.9% |
| Q1 2021 | $612,046,000 | -14.1% | 17,148,962 | -11.4% | 0.05% | -17.5% |
| Q4 2020 | $712,486,000 | -4.2% | 19,361,008 | -2.0% | 0.06% | -16.0% |
| Q3 2020 | $743,887,000 | -8.7% | 19,763,199 | -1.0% | 0.08% | -16.7% |
| Q2 2020 | $814,357,000 | +10.5% | 19,964,614 | +2.6% | 0.09% | -11.8% |
| Q1 2020 | $737,231,000 | -18.5% | 19,457,142 | +1.1% | 0.10% | +2.0% |
| Q4 2019 | $904,560,000 | +9.2% | 19,250,075 | -0.8% | 0.10% | +1.0% |
| Q3 2019 | $828,272,000 | +13.3% | 19,406,569 | +6.2% | 0.10% | +16.5% |
| Q2 2019 | $731,160,000 | +0.3% | 18,269,876 | +4.7% | 0.08% | -2.3% |
| Q1 2019 | $729,152,000 | +8.4% | 17,447,988 | -0.9% | 0.09% | -5.4% |
| Q4 2018 | $672,571,000 | -12.3% | 17,601,950 | -7.8% | 0.09% | +7.0% |
| Q3 2018 | $766,495,000 | +1.4% | 19,081,274 | +1.7% | 0.09% | -1.1% |
| Q2 2018 | $755,956,000 | +2.0% | 18,753,553 | -1.1% | 0.09% | -1.1% |
| Q1 2018 | $741,195,000 | +6.2% | 18,970,950 | -3.6% | 0.09% | +7.3% |
| Q4 2017 | $698,074,000 | -13.6% | 19,680,711 | -1.1% | 0.08% | -16.3% |
| Q3 2017 | $807,885,000 | -25.1% | 19,898,632 | -20.5% | 0.10% | -26.9% |
| Q2 2017 | $1,079,047,000 | +8.3% | 25,024,276 | +5.9% | 0.13% | +5.5% |
| Q1 2017 | $996,452,000 | +22.3% | 23,635,038 | +11.7% | 0.13% | +16.5% |
| Q4 2016 | $814,603,000 | -11.8% | 21,153,029 | -1.2% | 0.11% | -11.4% |
| Q3 2016 | $923,645,000 | +2.9% | 21,415,404 | +3.4% | 0.12% | +0.8% |
| Q2 2016 | $897,198,000 | +38.8% | 20,701,378 | +29.8% | 0.12% | +37.1% |
| Q1 2016 | $646,534,000 | +16.9% | 15,944,140 | +16.3% | 0.09% | +20.3% |
| Q4 2015 | $552,967,000 | +26.1% | 13,704,243 | +20.2% | 0.07% | +19.4% |
| Q3 2015 | $438,420,000 | -4.1% | 11,402,363 | +3.9% | 0.06% | +5.1% |
| Q2 2015 | $457,141,000 | -20.4% | 10,975,769 | -11.8% | 0.06% | -19.2% |
| Q1 2015 | $574,542,000 | +18.7% | 12,449,443 | +9.9% | 0.07% | +15.9% |
| Q4 2014 | $483,966,000 | +9.0% | 11,323,488 | +17.2% | 0.06% | +5.0% |
| Q3 2014 | $444,033,000 | +28.0% | 9,659,197 | +48.9% | 0.06% | +27.7% |
| Q2 2014 | $347,000,000 | -1.5% | 6,488,392 | -1.6% | 0.05% | -4.1% |
| Q1 2014 | $352,275,000 | -2.2% | 6,593,205 | -2.3% | 0.05% | -3.9% |
| Q4 2013 | $360,333,000 | -30.5% | 6,749,076 | -34.7% | 0.05% | -35.4% |
| Q3 2013 | $518,365,000 | -10.5% | 10,332,168 | -10.8% | 0.08% | -16.8% |
| Q2 2013 | $578,885,000 | – | 11,584,665 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |